Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Elise Deluke

Dermatology Amherst, NY Medical Doctor

NPI 1265708267 CMS profile 1533986

4949 Main St, Amherst, NY 14226

Open in the dashboard

General payments

$17,314

987 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Elise Deluke of Amherst, NY is reported in the CMS Open Payments database as having received $17,314 across 987 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,599 164
2024 General $3,220 178
2023 General $2,367 125
2022 General $2,823 158
2021 General $2,132 111
2020 General $1,512 84
2019 General $2,660 167

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Elise Deluke
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Elise Deluke were reported at $2,599. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Elise Deluke Dermatology median Middle half National median
2019 $2,660 $454 $129–$1,240 $163
2020 $1,512 $235 $81–$756 $114
2021 $2,132 $377 $108–$1,108 $132
2022 $2,823 $514 $143–$1,391 $149
2023 $2,367 $607 $159–$1,674 $160
2024 $3,220 $751 $204–$1,903 $164
2025 $2,599 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $3,418 194 payments
  2. Janssen Biotech, Inc. $1,630 78 payments
  3. Sun Pharmaceutical Industries Inc. $1,230 67 payments
  4. Genzyme Corporation $1,053 48 payments
  5. Lilly USA, LLC $969 51 payments
  6. Galderma Laboratories, L.P. $926 68 payments
  7. Amgen Inc. $891 54 payments
  8. Pfizer Inc. $851 62 payments
  9. UCB, Inc. $777 45 payments
  10. LEO Pharma Inc. $765 38 payments
  11. Other $4,803 282 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $16,807 981 payments
  2. Education $507 6 payments
Products named General payments · program years 2019–2025
  1. SKYRIZI $1,504 86 payments
  2. TREMFYA $1,415 57 payments
  3. DUPIXENT $1,372 60 payments
  4. RINVOQ $1,101 53 payments
  5. TALTZ $895 48 payments
  6. Otezla $891 54 payments
  7. HUMIRA $862 55 payments
  8. ILUMYA $850 45 payments
  9. EUCRISA $671 51 payments
  10. OPZELURA $636 43 payments
  11. Other $10,104 629 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 27 drugs

Part D claims

1,078

Median for Dermatology: 534

Drug cost

$527,150

Median for Dermatology: $67,151

Branded share of claims

10.6%

Median for Dermatology: 8.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Skyrizi Pen Risankizumab-Rzaa Brand 11 $221,187
Dupixent Pen Dupilumab Brand 52 $191,848
Otezla Apremilast Brand 13 $83,576
Pimecrolimus Generic 13 $6,657
Clobetasol Propionate Generic 165 $4,475
Ketoconazole Generic 191 $3,757
Metronidazole Generic 39 $2,675
Tacrolimus Generic 20 $2,504
Tretinoin Generic 27 $1,638
Fluorouracil Generic 24 $1,218

The 10 drugs with the highest cost, of 27 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,550 Part D prescribers listed as Dermatology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 35 billing codes

Paid by Medicare

$41,916

Medicare's payments for the services billed

Medicare patients

251

Average age 74

Services billed

1,137

141 women, 110 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 65%
Arthritis 51%
Chronic kidney disease 27%
Ischemic heart disease 23%
Diabetes 19%
Cancer 18%
Depression 18%
Atrial fibrillation 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 26 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
SKYRIZI
$389 11 —
DUPIXENT
$309 52 —
RINVOQ
$296 — —
SOTYKTU
$286 — —
Otezla
$270 13 —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 26 with Patron

Records

987 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record